196 related articles for article (PubMed ID: 27875319)
1. Enhanced oral bioavailability of metoprolol with gallic acid and ellagic acid in male Wistar rats: involvement of CYP2D6 inhibition.
Athukuri BL; Neerati P
Drug Metab Pers Ther; 2016 Dec; 31(4):229-234. PubMed ID: 27875319
[TBL] [Abstract][Full Text] [Related]
2. Enhanced oral bioavailability of linagliptin by the influence of gallic acid and ellagic acid in male Wistar albino rats: involvement of p-glycoprotein inhibition.
Shaik M; Vanapatla SR
Drug Metab Pers Ther; 2019 Jun; 34(2):. PubMed ID: 31256062
[TBL] [Abstract][Full Text] [Related]
3. Enhanced Oral Bioavailability of Diltiazem by the Influence of Gallic Acid and Ellagic Acid in Male Wistar Rats: Involvement of CYP3A and P-gp Inhibition.
Athukuri BL; Neerati P
Phytother Res; 2017 Sep; 31(9):1441-1448. PubMed ID: 28766866
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetic drug interactions of gefitinib with rifampicin, itraconazole and metoprolol.
Swaisland HC; Ranson M; Smith RP; Leadbetter J; Laight A; McKillop D; Wild MJ
Clin Pharmacokinet; 2005; 44(10):1067-81. PubMed ID: 16176119
[TBL] [Abstract][Full Text] [Related]
5. The oral bioavailability, excretion and cytochrome P450 inhibition properties of epiberberine: an in vivo and in vitro evaluation.
Chen N; Yang XY; Guo CE; Bi XN; Chen JH; Chen HY; Li HP; Lin HY; Zhang YJ
Drug Des Devel Ther; 2018; 12():57-65. PubMed ID: 29343943
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of CYP2D6 by quinidine and its effects on the metabolism of cilostazol.
Bramer SL; Suri A
Clin Pharmacokinet; 1999; 37 Suppl 2():41-51. PubMed ID: 10702886
[TBL] [Abstract][Full Text] [Related]
7. Comparison of CYP2D6 content and metoprolol oxidation between microsomes isolated from human livers and small intestines.
Madani S; Paine MF; Lewis L; Thummel KE; Shen DD
Pharm Res; 1999 Aug; 16(8):1199-205. PubMed ID: 10468020
[TBL] [Abstract][Full Text] [Related]
8. Metoprolol-pridopidine drug-drug interaction and food effect assessments of pridopidine, a new drug for treatment of Huntington's disease.
Rabinovich-Guilatt L; Steiner L; Hallak H; Pastino G; Muglia P; Spiegelstein O
Br J Clin Pharmacol; 2017 Oct; 83(10):2214-2224. PubMed ID: 28449367
[TBL] [Abstract][Full Text] [Related]
9. Effects of suberoylanilide hydroxamic acid on rat cytochrome P450 enzyme activities.
Lin K; Zhang Q; Liu Z; Yang S; Lin Y; Wen C; Zheng Y
Int J Clin Exp Pathol; 2015; 8(5):5584-90. PubMed ID: 26191268
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics and CYP2D6 genotypes do not predict metoprolol adverse events or efficacy in hypertension.
Zineh I; Beitelshees AL; Gaedigk A; Walker JR; Pauly DF; Eberst K; Leeder JS; Phillips MS; Gelfand CA; Johnson JA
Clin Pharmacol Ther; 2004 Dec; 76(6):536-44. PubMed ID: 15592325
[TBL] [Abstract][Full Text] [Related]
11. Influence of hydroxychloroquine on the bioavailability of oral metoprolol.
Somer M; Kallio J; Pesonen U; Pyykkö K; Huupponen R; Scheinin M
Br J Clin Pharmacol; 2000 Jun; 49(6):549-54. PubMed ID: 10848718
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetic model incorporating mechanism-based inactivation of CYP2D6 can explain both non-linear kinetics and drug interactions of paroxetine.
Mikami A; Ohtani H; Hori S; Sawada Y
Int J Clin Pharmacol Ther; 2013 May; 51(5):374-82. PubMed ID: 23357843
[TBL] [Abstract][Full Text] [Related]
13. Discontinuation and dose adjustment of metoprolol after metoprolol-paroxetine/fluoxetine co-prescription in Dutch elderly.
Bahar MA; Wang Y; Bos JHJ; Wilffert B; Hak E
Pharmacoepidemiol Drug Saf; 2018 Jun; 27(6):621-629. PubMed ID: 29575226
[TBL] [Abstract][Full Text] [Related]
14. Mechanism-Based Inactivation of CYP2D6 by Phellopterin and Related Drug-Drug Interaction with Metoprolol.
Cheng Z; He Y; Chen Y; Zhao G; Liu Y; Zhang J; Li X; Ran G; Zhang Q; Peng Y; Li W; Zheng J
J Agric Food Chem; 2024 Jan; 72(3):1745-1755. PubMed ID: 38214270
[TBL] [Abstract][Full Text] [Related]
15. Absolute oral bioavailability of traxoprodil in cytochrome P450 2D6 extensive and poor metabolisers.
Taylor TJ; Diringer K; Russell T; Venkatakrishnan K; Wilner K; Crownover PH; Benincosa LJ; Gibbs MA
Clin Pharmacokinet; 2006; 45(10):989-1001. PubMed ID: 16984212
[TBL] [Abstract][Full Text] [Related]
16. Lotus leaf alkaloid fraction can strongly inhibit CYP2D6 isoenzyme activity.
Ye LH; Kong LT; Yan MZ; Cao FR; Wang LS; Liao YH; Pan RL; Chang Q
J Ethnopharmacol; 2016 Dec; 194():913-917. PubMed ID: 27771456
[TBL] [Abstract][Full Text] [Related]
17. Effect of the potent CYP2D6 inhibitor sarpogrelate on the pharmacokinetics and pharmacodynamics of metoprolol in healthy male Korean volunteers.
Cho DY; Bae SH; Lee JK; Park JB; Kim YW; Lee S; Oh E; Kim BT; Bae SK
Xenobiotica; 2015 Mar; 45(3):256-63. PubMed ID: 25268386
[TBL] [Abstract][Full Text] [Related]
18. In Vitro CYP2D Inhibitory Effect and Influence on Pharmacokinetics and Pharmacodynamic Parameters of Metoprolol Succinate by Terminalia arjuna in Rats.
Varghese A; Savai J; Mistry S; Khandare P; Barve K; Pandita N; Gaud R
Drug Metab Lett; 2016; 10(2):124-35. PubMed ID: 26891872
[TBL] [Abstract][Full Text] [Related]
19. Physiologically Based Pharmacokinetic Modeling to Assess the Impact of CYP2D6-Mediated Drug-Drug Interactions on Tramadol and O-Desmethyltramadol Exposures via Allosteric and Competitive Inhibition.
Long T; Cristofoletti R; Cicali B; Michaud V; Dow P; Turgeon J; Schmidt S
J Clin Pharmacol; 2022 Jan; 62(1):76-86. PubMed ID: 34383318
[TBL] [Abstract][Full Text] [Related]
20. Influence of Zuojin Pill on the Metabolism of Venlafaxine in Vitro and in Rats and Associated Herb-Drug Interaction.
Li Y; Li J; Yan D; Wang Q; Jin J; Tan B; Qiu F
Drug Metab Dispos; 2020 Oct; 48(10):1044-1052. PubMed ID: 32561594
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]